Results 1 to 10 of about 179,072 (377)

VinDr-Mammo: A large-scale benchmark dataset for computer-aided diagnosis in full-field digital mammography [PDF]

open access: yesarXiv, 2022
Mammography, or breast X-ray, is the most widely used imaging modality to detect cancer and other breast diseases. Recent studies have shown that deep learning-based computer-assisted detection and diagnosis (CADe or CADx) tools have been developed to support physicians and improve the accuracy of interpreting mammography.
H. T. Nguyen   +6 more
arxiv   +3 more sources

Contrast-enhanced Mammography: State of the Art.

open access: yesRadiology, 2021
Contrast-enhanced mammography (CEM) has emerged as a viable alternative to contrast-enhanced breast MRI, and it may increase access to vascular imaging while reducing examination cost.
M. Jochelson, M. Lobbes
semanticscholar   +1 more source

An image quality review programme in a population‐based mammography screening service

open access: yesJournal of Medical Radiation Sciences, 2021
Introduction Mammography is one of the most technically demanding radiographic processes, and mammography quality assurance initiatives are priorities in the implementation of public health screening services.
Vania Galli   +4 more
doaj   +1 more source

Impact of loss functions on the performance of a deep neural network designed to restore low-dose digital mammography [PDF]

open access: yesArtificial Intelligence In Medicine, 142(2023), 102555, 2023, 2021
Digital mammography is still the most common imaging tool for breast cancer screening. Although the benefits of using digital mammography for cancer screening outweigh the risks associated with the x-ray exposure, the radiation dose must be kept as low as possible while maintaining the diagnostic utility of the generated images, thus minimizing patient
arxiv   +1 more source

Changes in Mammography Utilization by Women’s Characteristics during the First 5 Months of the COVID-19 Pandemic

open access: yesJournal of the National Cancer Institute, 2021
Background The coronavirus disease 2019 (COVID-19) pandemic led to a near-total cessation of mammography services in the United States in mid-March 2020.
B. Sprague   +12 more
semanticscholar   +1 more source

Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer

open access: yesJournal of Medical Screening, 2021
Objectives Mammography screening is generally accepted in women aged 50–69, but the balance between benefits and harms remains controversial in other age groups.
C. Canelo-Aybar   +12 more
semanticscholar   +1 more source

Blind-ending bifid ureter – a case report of rare congenital anomaly and its sonographic appearance

open access: yesJournal of Ultrasonography, 2022
We report a case of a blind-ending bifid ureter in a 67-year-old woman with ascites initially diagnosed with B-mode and Color Doppler ultrasonography and afterwards verified with contrast-enhanced abdominal computed tomography. A literature review of the
Łyczek Wojciech, Migda Bartosz
doaj   +1 more source

Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women

open access: yesCancer, 2020
It is of paramount importance to evaluate the impact of participation in organized mammography service screening independently from changes in breast cancer treatment.
S. Duffy   +33 more
semanticscholar   +1 more source

Lesions of “uncertain malignant potential” in the breast (B3) identified with mammography screening

open access: yesBMC Cancer, 2018
Background Core needle biopsy (CNB) is a standard diagnostic procedure in the setting of breast cancer screening. However, CNB may result in the borderline diagnoses of lesion of uncertain malignant potential (B3). The aim of this study was to access the
Christiane Richter-Ehrenstein   +3 more
doaj   +1 more source

Twenty five year follow-up for breast cancer incidence and mortality of the Canadian national breast screening study: randomised screening trial [PDF]

open access: yes, 2014
Annual mammography in women aged 40-59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available.
Anthony B. Miller   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy